APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vinpocetine

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis

Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).

Selected research

Market Structure

Global Vinpocetine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

25 December 2025199 pages

Choose your research edition.

Industry ResearchVinpocetine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Vinpocetine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Vinpocetine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vinpocetine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Vinpocetine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis

Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).

In the US market, the major manufacturers are Gedeon Richter, Runhong, Sun Pharma, WZT, Pude, Welman and Zhitong.

Read the full market overview

This report provides an overview of the global Vinpocetine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vinpocetine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vinpocetine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vinpocetine market size, projected growth trends, production technologies, key applications, and end-use industries.

Vinpocetine Segment by Company

Gedeon Richter

Runhong

Sun Pharma

WZT

PUDE

Welman

ZhiTong

Liaoning Zhiying

COVEX

Northeast Pharma

Micro Labs

Vinpocetine Segment by Type

Tablet

Injection

Vinpocetine Segment by Application

Household

Hospital

Vinpocetine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vinpocetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vinpocetine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vinpocetine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vinpocetine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vinpocetine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Vinpocetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Vinpocetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Vinpocetine Industry Trends Table 2. Vinpocetine Industry Drivers Table 3. Vinpocetine Industry Opportunities and Challenges Table 4. Vinpocetine Industry Restraints Table 5. Global Vinpocetine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Vinpocetine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Vinpocetine Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Vinpocetine Sales Market Share by Manufacturers Table 9. Global Vinpocetine Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Vinpocetine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Vinpocetine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Vinpocetine Manufacturers, Product Type & Application Table 13. Global Vinpocetine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Vinpocetine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Injection Table 18. Global Vinpocetine Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 19. Global Vinpocetine Sales by Type (2021-2026) & (M Units) Table 20. Global Vinpocetine Sales by Type (2027-2032) & (M Units) Table 21. Global Vinpocetine Sales Market Share by Type (2021-2026) Table 22. Global Vinpocetine Sales Market Share by Type (2027-2032) Table 23. Global Vinpocetine Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 24. Global Vinpocetine Revenue by Type (2021-2026) & (M Units) Table 25. Global Vinpocetine Revenue by Type (2027-2032) & (M Units) Table 26. Global Vinpocetine Revenue Market Share by Type (2021-2026) Table 27. Global Vinpocetine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Household Table 29. Major Manufacturers of Hospital Table 30. Global Vinpocetine Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 31. Global Vinpocetine Sales by Application (2021-2026) & (M Units) Table 32. Global Vinpocetine Sales by Application (2027-2032) & (M Units) Table 33. Global Vinpocetine Sales Market Share by Application (2021-2026) Table 34. Global Vinpocetine Sales Market Share by Application (2027-2032) Table 35. Global Vinpocetine Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 36. Global Vinpocetine Revenue by Application (2021-2026) & (M Units) Table 37. Global Vinpocetine Revenue by Application (2027-2032) & (M Units) Table 38. Global Vinpocetine Revenue Market Share by Application (2021-2026) Table 39. Global Vinpocetine Revenue Market Share by Application (2027-2032) Table 40. Global Vinpocetine Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 41. Global Vinpocetine Sales by Region (2021-2026) & (M Units) Table 42. Global Vinpocetine Sales Market Share by Region (2021-2026) Table 43. Global Vinpocetine Sales Forecasted by Region (2027-2032) & (M Units) Table 44. Global Vinpocetine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Vinpocetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 46. North America Vinpocetine Sales by Country (2021-2026) & (M Units) Table 47. North America Vinpocetine Sales by Country (2027-2032) & (M Units) Table 48. Europe Vinpocetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 49. Europe Vinpocetine Sales by Country (2021-2026) & (M Units) Table 50. Europe Vinpocetine Sales by Country (2027-2032) & (M Units) Table 51. Asia Pacific Vinpocetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 52. Asia Pacific Vinpocetine Sales by Country (2021-2026) & (M Units) Table 53. Asia Pacific Vinpocetine Sales by Country (2027-2032) & (M Units) Table 54. South America, Middle East and Africa Vinpocetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 55. South America, Middle East and Africa Vinpocetine Sales by Country (2021-2026) & (M Units) Table 56. South America, Middle East and Africa Vinpocetine Sales by Country (2027-2032) & (M Units) Table 57. Global Vinpocetine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Vinpocetine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Vinpocetine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Vinpocetine Revenue Market Share by Region (2021-2026) Table 61. Global Vinpocetine Revenue Market Share by Region (2027-2032) Table 62. Gedeon Richter Company Information Table 63. Gedeon Richter Business Overview Table 64. Gedeon Richter Vinpocetine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Gedeon Richter Vinpocetine Product Portfolio Table 66. Gedeon Richter Recent Development Table 67. Runhong Company Information Table 68. Runhong Business Overview Table 69. Runhong Vinpocetine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Runhong Vinpocetine Product Portfolio Table 71. Runhong Recent Development Table 72. Sun Pharma Company Information Table 73. Sun Pharma Business Overview Table 74. Sun Pharma Vinpocetine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sun Pharma Vinpocetine Product Portfolio Table 76. Sun Pharma Recent Development Table 77. WZT Company Information Table 78. WZT Business Overview Table 79. WZT Vinpocetine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. WZT Vinpocetine Product Portfolio Table 81. WZT Recent Development Table 82. PUDE Company Information Table 83. PUDE Business Overview Table 84. PUDE Vinpocetine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. PUDE Vinpocetine Product Portfolio Table 86. PUDE Recent Development Table 87. Welman Company Information Table 88. Welman Business Overview Table 89. Welman Vinpocetine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Welman Vinpocetine Product Portfolio Table 91. Welman Recent Development Table 92. ZhiTong Company Information Table 93. ZhiTong Business Overview Table 94. ZhiTong Vinpocetine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. ZhiTong Vinpocetine Product Portfolio Table 96. ZhiTong Recent Development Table 97. Liaoning Zhiying Company Information Table 98. Liaoning Zhiying Business Overview Table 99. Liaoning Zhiying Vinpocetine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Liaoning Zhiying Vinpocetine Product Portfolio Table 101. Liaoning Zhiying Recent Development Table 102. COVEX Company Information Table 103. COVEX Business Overview Table 104. COVEX Vinpocetine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. COVEX Vinpocetine Product Portfolio Table 106. COVEX Recent Development Table 107. Northeast Pharma Company Information Table 108. Northeast Pharma Business Overview Table 109. Northeast Pharma Vinpocetine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Northeast Pharma Vinpocetine Product Portfolio Table 111. Northeast Pharma Recent Development Table 112. Micro Labs Company Information Table 113. Micro Labs Business Overview Table 114. Micro Labs Vinpocetine Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Micro Labs Vinpocetine Product Portfolio Table 116. Micro Labs Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Vinpocetine Distributors List Table 120. Vinpocetine Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Vinpocetine Product Image Figure 2. Global Vinpocetine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vinpocetine Market Size (2021-2032) & (US$ Million) Figure 4. Global Vinpocetine Sales (2021-2032) & (M Units) Figure 5. Global Vinpocetine Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Vinpocetine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Injection Image Figure 10. Global Vinpocetine Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 11. Global Vinpocetine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Vinpocetine Sales Market Share by Type (2021-2032) Figure 13. Global Vinpocetine Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 14. Global Vinpocetine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Vinpocetine Revenue Market Share by Type (2021-2032) Figure 16. Household Image Figure 17. Hospital Image Figure 18. Global Vinpocetine Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 19. Global Vinpocetine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Vinpocetine Sales Market Share by Application (2021-2032) Figure 21. Global Vinpocetine Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 22. Global Vinpocetine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Vinpocetine Revenue Market Share by Application (2021-2032) Figure 24. North America Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 25. North America Vinpocetine Sales Market Share by Country (2021-2032) Figure 26. U.S. Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 27. Canada Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 28. Mexico Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 29. Europe Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 30. Europe Vinpocetine Sales Market Share by Country (2021-2032) Figure 31. Germany Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 32. France Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 33. U.K. Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 34. Italy Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 35. Netherlands Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Asia Pacific Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Asia Pacific Vinpocetine Sales Market Share by Country (2021-2032) Figure 38. China Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 39. Japan Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 40. South Korea Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 41. Southeast Asia Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 42. India Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 43. Australia Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 44. South America, Middle East and Africa Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 45. South America, Middle East and Africa Vinpocetine Sales Market Share by Country (2021-2032) Figure 46. Brazil Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 47. South Africa Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 48. Saudi Arabia Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 49. Turkey Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Argentina Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 51. UAE Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 52. Egypt Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Chile Vinpocetine Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Global Vinpocetine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Vinpocetine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Vinpocetine Revenue (2021-2032) & (US$ Million) Figure 57. North America Vinpocetine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Vinpocetine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Vinpocetine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Vinpocetine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Vinpocetine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Vinpocetine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Vinpocetine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Vinpocetine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Vinpocetine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Injection
Applications
  • Household
  • Hospital
Companies covered
  • Gedeon Richter
  • Runhong
  • Sun Pharma
  • WZT
  • PUDE
  • Welman
  • ZhiTong
  • Liaoning Zhiying
  • COVEX
  • Northeast Pharma
  • Micro Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Vinpocetine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Vinpocetine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Vinpocetine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Vinpocetine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Vinpocetine Market Dynamics
  1. 2.1 Vinpocetine Industry Trends
  2. 2.2 Vinpocetine Industry Drivers
  3. 2.3 Vinpocetine Industry Opportunities and Challenges
  4. 2.4 Vinpocetine Industry Restraints
3 Vinpocetine Market by Manufacturers
  1. 3.1 Global Vinpocetine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Vinpocetine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Vinpocetine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Vinpocetine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vinpocetine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Vinpocetine Manufacturers, Product Type & Application
  7. 3.7 Global Vinpocetine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vinpocetine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vinpocetine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vinpocetine Tier 1, Tier 2, and Tier 3
4 Vinpocetine Market by Type
  1. 4.1 Vinpocetine Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Injection
  4. 4.2 Global Vinpocetine Sales by Type
  5. 4.2.1 Global Vinpocetine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Vinpocetine Sales by Type (2021-2032)
  7. 4.2.3 Global Vinpocetine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Vinpocetine Revenue by Type
  9. 4.3.1 Global Vinpocetine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Vinpocetine Revenue by Type (2021-2032)
  11. 4.3.3 Global Vinpocetine Revenue Market Share by Type (2021-2032)
5 Vinpocetine Market by Application
  1. 5.1 Vinpocetine Application Introduction
  2. 5.1.1 Household
  3. 5.1.2 Hospital
  4. 5.2 Global Vinpocetine Sales by Application
  5. 5.2.1 Global Vinpocetine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Vinpocetine Sales by Application (2021-2032)
  7. 5.2.3 Global Vinpocetine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Vinpocetine Revenue by Application
  9. 5.3.1 Global Vinpocetine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Vinpocetine Revenue by Application (2021-2032)
  11. 5.3.3 Global Vinpocetine Revenue Market Share by Application (2021-2032)
6 Global Vinpocetine Sales by Region
  1. 6.1 Global Vinpocetine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vinpocetine Sales by Region (2021-2032)
  3. 6.2.1 Global Vinpocetine Sales by Region (2021-2026)
  4. 6.2.2 Global Vinpocetine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Vinpocetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Vinpocetine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Vinpocetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Vinpocetine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Vinpocetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Vinpocetine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Vinpocetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Vinpocetine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Vinpocetine Revenue by Region
  1. 7.1 Global Vinpocetine Revenue by Region
  2. 7.1.1 Global Vinpocetine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Vinpocetine Revenue by Region (2021-2026)
  4. 7.1.3 Global Vinpocetine Revenue by Region (2027-2032)
  5. 7.1.4 Global Vinpocetine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Vinpocetine Revenue (2021-2032)
  8. 7.2.2 North America Vinpocetine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Vinpocetine Revenue (2021-2032)
  11. 7.3.2 Europe Vinpocetine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Vinpocetine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Vinpocetine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Vinpocetine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Vinpocetine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Gedeon Richter
  2. 8.1.1 Gedeon Richter Company Information
  3. 8.1.2 Gedeon Richter Business Overview
  4. 8.1.3 Gedeon Richter Vinpocetine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Gedeon Richter Vinpocetine Product Portfolio
  6. 8.1.5 Gedeon Richter Recent Developments
  7. 8.2 Runhong
  8. 8.2.1 Runhong Company Information
  9. 8.2.2 Runhong Business Overview
  10. 8.2.3 Runhong Vinpocetine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Runhong Vinpocetine Product Portfolio
  12. 8.2.5 Runhong Recent Developments
  13. 8.3 Sun Pharma
  14. 8.3.1 Sun Pharma Company Information
  15. 8.3.2 Sun Pharma Business Overview
  16. 8.3.3 Sun Pharma Vinpocetine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharma Vinpocetine Product Portfolio
  18. 8.3.5 Sun Pharma Recent Developments
  19. 8.4 WZT
  20. 8.4.1 WZT Company Information
  21. 8.4.2 WZT Business Overview
  22. 8.4.3 WZT Vinpocetine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 WZT Vinpocetine Product Portfolio
  24. 8.4.5 WZT Recent Developments
  25. 8.5 PUDE
  26. 8.5.1 PUDE Company Information
  27. 8.5.2 PUDE Business Overview
  28. 8.5.3 PUDE Vinpocetine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PUDE Vinpocetine Product Portfolio
  30. 8.5.5 PUDE Recent Developments
  31. 8.6 Welman
  32. 8.6.1 Welman Company Information
  33. 8.6.2 Welman Business Overview
  34. 8.6.3 Welman Vinpocetine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Welman Vinpocetine Product Portfolio
  36. 8.6.5 Welman Recent Developments
  37. 8.7 ZhiTong
  38. 8.7.1 ZhiTong Company Information
  39. 8.7.2 ZhiTong Business Overview
  40. 8.7.3 ZhiTong Vinpocetine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ZhiTong Vinpocetine Product Portfolio
  42. 8.7.5 ZhiTong Recent Developments
  43. 8.8 Liaoning Zhiying
  44. 8.8.1 Liaoning Zhiying Company Information
  45. 8.8.2 Liaoning Zhiying Business Overview
  46. 8.8.3 Liaoning Zhiying Vinpocetine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Liaoning Zhiying Vinpocetine Product Portfolio
  48. 8.8.5 Liaoning Zhiying Recent Developments
  49. 8.9 COVEX
  50. 8.9.1 COVEX Company Information
  51. 8.9.2 COVEX Business Overview
  52. 8.9.3 COVEX Vinpocetine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 COVEX Vinpocetine Product Portfolio
  54. 8.9.5 COVEX Recent Developments
  55. 8.10 Northeast Pharma
  56. 8.10.1 Northeast Pharma Company Information
  57. 8.10.2 Northeast Pharma Business Overview
  58. 8.10.3 Northeast Pharma Vinpocetine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Northeast Pharma Vinpocetine Product Portfolio
  60. 8.10.5 Northeast Pharma Recent Developments
  61. 8.11 Micro Labs
  62. 8.11.1 Micro Labs Company Information
  63. 8.11.2 Micro Labs Business Overview
  64. 8.11.3 Micro Labs Vinpocetine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Micro Labs Vinpocetine Product Portfolio
  66. 8.11.5 Micro Labs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vinpocetine Value Chain Analysis
  2. 9.1.1 Vinpocetine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vinpocetine Production Mode & Process
  6. 9.2 Vinpocetine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vinpocetine Distributors
  9. 9.2.3 Vinpocetine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst